Bacterial protein synthesis is the target for several classes of established antibiotics. This report describes the characterization of a novel translation inhibitor produced by the soil bacterium Flexibacter. The dipeptide antibiotic TAN1057 A/B was synthesized and designated GS7128. As reported previously, TAN1057 inhibits protein synthesis in both Escherichia coli and Staphylococcus aureus, leaving transcription unaffected. Cell-free translation systems from E. coli were used to further dissect the mechanism of translational inhibition. Binding of mRNA to ribosomes was unaffected by the drug, whereas the initiation reaction was reduced. Elongation of translation was completely inhibited by GS7128. Detailed analysis showed that the peptidyl transferase reaction was strongly inhibited, whereas tRNA binding to both A-and P-site was unaffected. Selection and analysis of drug-resistant mutants of S. aureus suggests that drug uptake may be mediated by a dipeptide transport mechanism.
INTRODUCTION
Discovery of novel antimicrobial agents is an increasing challenge in the face of rapidly emerging resistant pathogens+ Most antibiotics used today are derivatives of compounds that have been in the clinic for more than 30 years+ In light of the inherent ability of microorganisms to change and adapt to new environments, identification of new classes of compounds is the best hope for developing safe and efficient antibacterials to combat resistant infections+ The approval of linezolid (Zyvox TM ) in 2000 was the first appearance of a new class of antibacterials since the introduction of the fluoroquinolones in the 1970s, a fact that illustrates the difficulties in the discovery of new drugs+ Linezolid belongs to a novel class of synthetic antibacterials, the oxazolidinones (Shinabarger et al+, 1997) , that are structurally unrelated to any other class of known antibiotics and act as bacteriostatic agents by blocking protein synthesis+ A large number of antibiotics affect protein synthesis, thus making translation an attractive and valid target for the development of new drugs+ Although translation in prokaryotes and eukaryotes are similar processes, they differ significantly with respect to number, sequence, and structure of the components involved (Merrick, 1994 )+ Highly selective agents, which include tetracycline, erythromycin, and streptomycin, preferentially inhibit prokaryotic ribosomes, leaving mammalian translation largely unaffected+ In contrast, nonselective agents such as puromycin, which interferes with both prokaryotic and mammalian translation, serve as invaluable tools for studies on ribosome structure and function (Nathans, 1964) + A new antibiotic compound, TAN 1057, was first isolated by researchers at Takeda Chemical Industries, Ltd+ (Funabashi et al+, 1993 )+ It is produced by certain strains of the Gram-negative soil bacterium Flexibacter and was shown to have in vitro and in vivo antibacterial activity, including activity against methicillin-resistant Staphylococcus aureus (MRSA; Katayama et al+, 1993 )+ Preliminary mechanism of action studies revealed that TAN 1057 inhibited protein biosynthesis (Katayama et al+, 1993) + TAN 1057 appears in four different conformations, designated A-D, which can be synthesized chemically (Williams et al+, 1998) + The molecule has a dipeptide-like structure, as shown in Figure 1+ We synthesized the diastereoisomer TAN 1057A/B and designated it GS7128+ Although the mixture can be separated into the component diastereoisomers, they spontaneously epimerize in solution (L+ Xu, unpub+ observations)+ Therefore, all the experiments described here were performed using a racemic mixture+
Here we report the results of a detailed analysis of the mechanism of action of GS7128+ We used both whole-cell and cell-free assays in Escherichia coli and S. aureus, first confirming that translation inhibition is indeed the primary target for these compounds, then dissected each step of the translation reaction, using isolated and purified reaction components+ We determined that the main target of inhibition is the peptidyl transferase reaction+ The site of this central step during protein elongation has been mapped to a core structure of the ribosome, the peptidyl transferase center located on the large ribosomal subunit (50S)+ Of the several known antibiotics known to bind onto ribosomal RNA at or near this site (Spahn & Prescott, 1996) , only chloramphenicol, tetracycline, and erythromycin are available in a radiolabeled form+ Based on competitive binding experiments, the binding site of GS7128 does not appear to overlap with them+ Implications of these findings as well as prospective studies will be discussed+
RESULTS

Bacterial and mammalian translation are equally inhibited by GS7128
It had been reported previously that TAN 1057 led to decreased protein synthesis in S. aureus and E. coli whereas DNA or RNA syntheses were not affected (Katayama et al+, 1993 )+ We synthesized the diastereoisomer TAN 1057A/B following published procedures (Williams et al+, 1998) , designated it GS7128, and analyzed its effects on protein synthesis and nucleic acid synthesis in S. aureus and in E. coli cells+ Bacteria were grown in standard media in the presence of either [ 3 H]uridine or [
35 S]methionine and incorporation of label was determined after TCA precipitation+ Transcription was unaffected by the addition of GS7128 (Fig+ 2A) whereas translation was strongly reduced (Fig+ 2B), confirming that protein synthesis is the main target for inhibition+ To further characterize the compound's effects on prokaryotic and mammalian cytosolic translation, cell-free translation extracts from E. coli and from rabbit reticulocytes were used+ Translation in E. coli FIGURE 1. Structure of the diastereoisomer GS7128+ FIGURE 2. Effects of GS7128 on protein and nucleic acid synthesis in whole S. aureus and E. coli cells+ The known transcription and translation inhibitors rifampicin (RIF) and streptomycin (STREP) were included as controls+ Cells were incubated for 30 min in the presence of antibiotic, precipitated with TCA, and filtered+ Bars represent counts per minute (cpm) after scintillation counting+ Drug was added prior to incubation up to a final concentration of 3 mg/mL GS7128, 0+5 mg/mL rifampicin, and 1 mg/mL streptomycin+ Values shown represent the average of two independent experiments+ A: Incorporation of [ 3 H]uridine into exponentially growing S. aureus and E. coli cells+ B: Incorporation of [ 35 S]methionine into exponentially growing S. aureus and E. coli cells+ was measured as expression of b-galactosidase activity derived from coupled transcription/translation of the SP6/b-gal vector+ Eukaryotic translation was assayed using a luciferase reporter gene+ The enzymatic activities of b-galactosidase and luciferase reporter gene products were unaffected by the presence of the drug (data not shown)+ Inhibition of translation was determined at a range of different drug concentrations and IC 50 values were calculated+ GS7128 inhibited both prokaryotic and mammalian cytosolic translation with IC 50 values of 0+15 mg/mL in bacteria (Fig+ 3A) and 0+1 mg/mL in rabbit reticulocyte lysate (Fig+ 3B)+
Initiation of translation is partially inhibited by GS7128
The sequence of events leading to translation of mRNA into protein begins with the binding of mRNA to small ribosomal subunits (30S)+ To determine whether GS7128 interferes with this process, binding of a radiolabeled mRNA template to E. coli ribosomes was measured using a filter-binding assay+ No inhibition of this interaction was observed using purified ribosomes, either alone or together with a complete cytoplasmic extract (Fig+ 4A)+ Formation of a full initiation complex was analyzed using [
35 S]methionine and tRNA fMet in a cellfree translation system+ Incorporation of label into initiation complexes was determined by filter binding and compared to known initiation inhibitors+ To ensure that incorporated label reflected the initiation step only, the antibiotic puromycin was included in the reaction, because it inhibits all subsequent translation steps but not initiation+ Under these conditions, GS7128 caused reduction of initiation complex formation (Fig+ 4B)+ However, this inhibition did not exceed 50% of the control, even after increasing the drug concentration to 128 mg/mL (data not shown), which corresponds to a 1,000-fold excess over the IC 50 for translation (see Fig+ 3A)+ Control reactions included known initiation inhibitors aurintricarboxylic acid (ATA) and tetracycline+ ATA led to complete inhibition of initiation whereas tetracycline, like GS7128, only partially reduced tRNA fMet binding, as was reported previously (Geigenmuller & Nierhaus, 1986 )+
Elongation is inhibited by GS7128
For an analysis of elongation independent of initiation, a poly(U)-dependent poly(Phe) assay was employed+ Synthesis of polyphenylalanine in cell extracts does not require initiation factors and radiolabeled [
14 C]phenylalanine is incorporated into TCA-precipitable peptides and measured by filtration+ We prepared cell-free extracts from S. aureus, which were functionally comparable to commercially available E. coli extracts+ Addition of GS7128 led to complete inhibition of elongation in both systems, indicating that the target for inhibition by this compound is conserved between both bacteria+ The IC 50 in E. coli was 1+4 mg/mL (Fig+ 5A) and in S. aureus 1+7 mg/mL (Fig+ 5B)+ It should be noted that the inhibitory concentrations were about 10-fold higher than for heteropolymeric mRNAs, indicating intrinsic differences between these two assay systems+ Although we have not explored this observation in more detail, it is possible that differences in mRNA concentration play an important role+
GS7128 inhibits the peptidyl transferase reaction
The core events during elongation in E. coli were analyzed in greater detail+ Ribosomes and elongation fac-FIGURE 3. IC 50 determination of GS7128+ Translation of a reporter gene was measured in cell-free extracts of E. coli and rabbit reticulocyte lysate (RRL)+ GS7128 was added at a range of concentrations from 0+02 to 2+56 mg/mL, and inhibition was expressed as percentage of uninhibited control+ Values shown represent the average of three independent experiments+ A: Translation of a b-galactosidase reporter gene in E. coli S30 extracts+ B: Translation of a luciferase reporter gene in RRL+ tors EF-Tu and EF-G were purified as described in Materials and Methods+ Two tRNAs, Ac-Phe-tRNA Phe and deacyl tRNA Phe , were radiolabeled and used in filter-binding assays to study effects of GS7128 on binding of tRNAs to the A-and P-sites of the ribosome+ The purified ribosomes, tRNAs, and elongation factors were assembled in specific combinations and sequences+ First, Ac-Phe-tRNA Phe was combined with purified ribosomes+ Ac-Phe-tRNA Phe mimics initiator fMet-tRNA binding and exclusively occupies the P-site (SchillingBartetzko et al+, 1992)+ Therefore, binding of this tRNA is used to evaluate availability of the P-site+ Next, ribosomes were combined with deacyl tRNA Phe + Enzymatic A-site binding can be analyzed by first blocking the P-site with deacyl tRNA Phe , then adding a preassembled ternary complex of EF-Tu, GTP, and radiolabeled Phe-tRNA Phe (Rheinberger et al+, 1981 )+ Finally, EF-G and GTP were added to this reaction, causing translocation of tRNAs such that the radiolabeled PhetRNA Phe now occupies the P-site+ At steps I and II, filter binding was used to quantitate the tRNA bound to the A-or P-site in the presence or absence of GS7128+ Additionally, puromycin was added to assess bindingsite specificity of bound tRNAs and peptidyl transferase activity+ Puromycin acts as an analog of the aminoacyl adenosine end of tRNA and will only bind to empty A-sites where it forms a peptide bond with the radiolabeled amino acid present at the P-site (Nathans, 1964 )+ However, further elongation is blocked because puromycin has no terminal carboxyl group+ The newly formed radiolabeled dipeptide can be extracted into ethyl acetate+ Thus, extracted counts serve as a mea-FIGURE 4. Steps during initiation of translation+ A: Radiolabeled mRNA was bound to ribosomes in the absence or presence of GS7128 (5 mg/mL)+ Binding efficiency was measured as scintillation counts after filtration+ RNA was bound to either purified (salt-washed) ribosomes or to ribosomes in a complete cytoplasmic extract+ Values shown represent the average of two independent experiments+ B: Radiolabeled initiator [
35 S]fMet tRNA fMet was bound to a ribosome-mRNA complex+ Drugs were added at 5 mg/mL GS7128, 10 mg/mL tetracycline (TET), or 100 mg/mL aurintricarboxylic acid (ATA)+ Binding was determined by filtration and scintillation counting+ Values are shown as percentage of the control reaction containing only puromycin and represent the average of three independent experiments+ FIGURE 5. Inhibition of poly(U)dependent poly(Phe) synthesis in cell-free extracts from E. coli and S. aureus. Activity was determined as incorporation of radiolabeled [
14 C]phenylalanine into TCA-precipitable peptides+ GS7128 was added at a range of concentrations from 0+2 to 25+6 mg/mL and inhibition was expressed as percentage of uninhibited control+ Values shown represent an average of three independent experiments+ A: Translation of poly(U) in E. coli S30 extracts+ B: Translation of poly(U) in S. aureus S30 extracts+ Mechanism of action of GS7128 1123 sure for A-site availability at each step, and also indicate successful translocation of tRNA from the A-to the P-site+ The results of these experiments are shown in Figure 6A and B+ No inhibition of tRNA binding to P-and A-sites was observed by the addition of GS7128 to the binding reactions described above (Fig+ 6A)+ As expected, the puromycin reaction shows A-site availability during P-site occupation and after translocation of A-site-bound tRNA (Fig+ 6B, w/o GS7128)+ However, in the presence of GS7128, puromycin reactivity was strongly inhibited (Fig+ 6B)+ The binding experiments described above exclude the possibility that GS7128 inhibits A-site binding, and we therefore conclude that it inhibits the peptidyl transferase reaction+
Effects of medium on drug activity
In agreement with previous studies (Katayama et al+, 1993) , we found that the growth medium affects the antibacterial activity of GS7128+ In Mueller-Hinton (MH) medium, the minimal inhibitory concentration (MIC) was 4-8 mg/mL, but it was dramatically lowered to 0+03 mg/mL when using a defined minimal medium (AOAC; Table 1), whereas the MICs of several control antibiotics were unchanged+ Because GS7128 resembles a dipeptide molecule, we speculated that specific dipeptide transporters could be involved in its uptake and high levels of competing peptides present in the medium could adversely affect drug uptake+ Such peptide transport systems have been identified in S. aureus, E. coli, and other bacteria, and are especially well characterized for Lactococcus lactis (Higgins & Gibson, 1986 )+ As shown in Table 1 , addition of dipeptides to AOAC medium raised the MIC to a value comparable to that observed in complex medium, whereas none of the control antibiotics showed any sensitivity to the change in medium+ These results suggest that dipeptides present in the culture medium may compete for cellular drug uptake+
Resistance in S. aureus
To study mutations in S. aureus conferring resistance to GS7128, wild-type S. aureus cells were plated on FIGURE 6. Effects of GS7128 on the steps of the elongation cycle+ Radiolabeled charged tRNAs were bound to A-and P-sites of the ribosome in the absence or presence of 5 mg/mL GS7128+ Binding was measured by filtration and site specificity by the puromycin reaction+ Values shown represent the average of two independent experiments+ A: Binding of tRNAs to P-and A-sites of the ribosome, in the absence or presence of GS7128+ Ac-Phe tRNA Phe was bound directly to the P-site+ Phe-tRNA Phe was enzymatically bound to the A-site after blocking the P-site with deacyl tRNA Phe + B: Puromycin reaction of samples at each step of the elongation cycle, in the absence or presence of GS7128+ ]methionine incorporation into whole cells+ In this assay, the mutant had a 100-fold reduced sensitivity to GS7128+ The same mutant was also analyzed for possible cross-resistance against tetracycline, chloramphenicol, and erythromycin+ However, no reduced sensitivity was observed against any of these drugs, suggesting that the mechanisms of resistance towards these antibiotics are different (Table 2) + To further analyze translation inhibition, cell-free extracts of both wild-type and mutant S. aureus were prepared and poly(U)-directed poly(Phe) synthesis was evaluated+ Both wild-type and mutant extracts supported translation at similar rates and showed no difference in the degree of translation inhibition (data not shown)+ This result implies that the mechanism of resistance is not due to alterations in ribosomes or translation factors+ In light of the results of the dipeptide competition experiments described above, it is possible that alterations of the dipeptide transport mechanism are responsible for a decreased uptake of drug into the cells+ DISCUSSION A previous study suggested that translation is the target of TAN 1057, a novel antibacterial compound isolated from Flexibacter strains (Katayama et al+, 1993 )+ In our study, we analyzed discrete steps of translation in order to dissect the specific mechanism of action+ Here we report that this compound, synthesized at Gilead Sciences and designated GS7128, inhibits protein synthesis in E. coli, S. aureus, and rabbit reticulocyte lysates, and that it specifically inhibits the peptidyl transferase reaction+
We began detailed mechanism-of-action studies by examining the drug's effects on initiation+ Initiation of protein synthesis requires the assembly of small ribosomal subunits (30S), mRNA, and tRNA fMet + When these steps were tested separately, no inhibition of mRNA binding to ribosomes was observed and only a modest effect on initiation complex formation was observed+ The control antibiotic tetracycline acts similarly in that it only partially blocks the initiation reaction+ For tetracycline, this phenomenon has been studied previously and was attributed to the presence of two distinct ribosomal conformations, only one of which is susceptible to the drug (Geigenmuller & Nierhaus, 1986 )+ GS7128 could be acting in a similar way, thereby causing only partial inhibition, even when used at high concentrations+ Dissection of the elongation cycle led to identification of the main target for translational inhibition by GS7128+ Initial experiments showed that poly(U)-dependent poly(Phe) synthesis was inhibited completely (Fig+ 5), indicating that elongation is affected+ The single steps of the elongation cycle were then analyzed using full ribosomes, tRNAs, and elongation factors+ Our experiments showed that binding of specific tRNAs to both P-site and A-site was unaffected by GS7128 (Fig+ 6A), whereas the puromycin reaction was strongly inhibited (Fig+ 6B)+ Puromycin is a structural tRNA analog that binds to the A-site and forms a covalent bond to the P-site residue+ This reaction is used to assess A-site availability and measure peptidyl transferase activity of the ribosome+ In fact, it has historically served as the main tool to define A-and P-sites on the ribosome (Nathans, 1964 )+ Inhibition of this reaction can be interpreted as either inhibition of A-site binding or of peptidyl transferase activity+ The binding experiments clearly rule out inhibition of A-site binding by GS7128 (Fig+ 6A), and we therefore conclude that the drug affects the intrinsic activity of the ribosome in its ability to catalyze formation of a peptide bond+
The mechanism of action of GS7128 is distinct from another new translational inhibitor, linezolid+ Linezolid is a novel antibacterial of the oxazolidinone class that was shown to interfere with protein translation+ Reports on the mechanism of action of oxazolidinones differ as to the step of translation that is inhibited, and both initiation and elongation reaction seem to be affected (Eustice et al+, 1988; Shinabarger et al+, 1997; Swaney et al+, 1998) + Oxazolidinones have been shown to directly bind to ribosomal RNA of both ribosomal subunits (Matassova et al+, 1999) , and oxazolidinoneresistant mutants display mutations in the 23S rRNA (Xiong et al+, 2000) + Recently it was reported that oxazolidinones inhibit P-site binding and thereby the formation of the first peptide bond (Patel et al+, 2001 )+ We tested linezolid in elongation reactions, and, in contrast to GS7128, we found no inhibition of either tRNA bind- Mechanism of action of GS7128 1125 ing or peptidyl transferase activity (data not shown)+ These results are at odds with the findings of Patel et al+ (2001) , but are consistent with the findings of Matassova et al+ (1999) , who reported that both P-site binding and EF-Tu-dependent A-site binding of tRNA were not affected by addition of oxazolidinones+ We conducted experiments aimed at determining the possible binding site of GS7128+ Only a few antibiotics known to bind to ribosomal RNA are available in a radiolabeled form+ In competition experiments with radiolabeled tetracycline, chloramphenicol, and erythromycin, GS7128 did not reduce binding of these antibiotics, indicating that their respective binding sites do not overlap+ This does not exclude the possibility of GS7128 binding to the 23S RNA at or close to the peptidyl transferase center, thus interfering with ribosome function+ Further experiments using footprinting assays are required to address this question+
We selected drug-resistant mutants with the aim of finding alterations in translational components that would elucidate the mechanism of action of GS7128+ However, we found that one-step selection procedures consistently yielded mutants that were not resistant to GS7128 at the translational level, even when whole cells showed resistance+ Many of the mutants were slow-growing and formed small colonies+ Almost without exception, mutants with stable resistance to GS7128 grew more slowly than wild type, and consequently were difficult to grow to concentrations needed to prepare extracts competent for translation+ It is conceivable that more rigorous selection methods and more painstaking growth techniques could isolate and characterize mutants in rRNA that are resistant to GS7128; such strains may carry additional compensatory mutations that confer viability sufficient for experimentation+ GS7128 may be limited as a potential therapeutic agent in humans for several reasons+ Because it nonselectively inhibits both prokaryotic and eukaryotic translation (Fig+ 3), it would potentially have toxic effects in animals, and our initial studies in mice confirmed this (J+ Watson, unpubl+ observations)+ Using these same in vitro assays, we found that the ratio of IC 50 in eukaryotic translation to IC 50 in prokaryotic translation for several approved antibiotics ranged from 50 (tetracycline) to .600 (erythromycin)+ Further studies would be required to identify derivatives of GS7128 with more favorable selectivity profiles+ We also found that mutants resistant to GS7128 were readily isolated, which may also limit the clinical utility of this molecule+ Finally, the results of our testing in different media suggest that GS7128 requires active transport for uptake and that uptake may be competitively reduced by dipeptides+ If GS7128 derivatives were found that did not rely on active transport mechanisms, this class of molecule might be more promising+ A small molecule that could passively enter bacterial cells but still inhibit peptidyl transferase would be a more useful starting point for the next necessary step of optimization-that is, selective inhibition of bacterial versus mammalian translation+ Recent publications describing the crystal structure of the bacterial ribosome (Ban et al+, 2000; Brodersen et al+, 2000; Schlunzen et al+, 2001; Yusupov et al+, 2001 ) are exciting breakthroughs and will likely have profound effects on drug discovery+ GS7128 is interesting as a new tool and, like puromycin, may provide important insight into structure and function of the ribosome+
MATERIALS AND METHODS
Materials
GS7128 was synthesized at Gilead Sciences according to published procedures (Williams et al+, 1998 )+ Chloramphenicol, tetracycline, erythromycin, streptomycin, aurintricarboxylic acid, and puromycin were obtained from Sigma+ Bacterial strains of E. coli (MRE600) and S. aureus were obtained from ATCC+ E. coli S30 and rabbit reticulocyte lysate (RRL) translation extracts were obtained from Promega+ Radiolabeled compounds used in this study were purchased from Amersham+ All other chemicals were purchased from Sigma+ Whole-cell labeling of E. coli and S. aureus Cells were grown in standard LB medium to a density of 0+5 (OD 600 )+ Antibiotics were added to each 100-mL aliquot of cells to achieve the final concentrations shown in the Figure 2 legend and preincubated for 5 min at 37 8C+ Labeling was initiated by the addition of 1 mCi [ 3 H]uridine or [ 35 S]methionine, and incubation was continued for 30 min at 37 8C+ The reaction was stopped by the addition of 500 mL ice-cold trichloroacetic acid (TCA 5%), the samples were boiled for 10 min, cooled on ice, and filtrated over glass-microfiber filters (Schleicher and Schuell)+ Results are expressed as percentage of uninhibited control after subtraction of background values+
Translation in E. coli extracts
Promega's E. coli S30 extract system for linear templates was used according to the manufacturer's instructions+ The pGEM vector (Promega) was used as DNA template and translation was quantified as b-galactosidase activity, using an assay kit from Stratagene+ Briefly, 6 mL of S30 extract were preincubated with or without GS7128 in a range of concentrations (see Fig+ 3)+ To this reaction, 3 mL amino acids, 10 mL premix (Promega), and 3 mL pGEM DNA were added in a total volume of 25 mL+ Incubation was carried out at 37 8C for 30 min, after which aliquots were transferred to 96-well plates and o-nitrophenyl-b-D-galactopyranoside was added to start the reaction+ Kinetic measurement of color development was taken in a Microplate reader at 420 nm (Molecular Devices) and calculated to yield IC 50 results using Sigmaplot+
Translation in RRL
Rabbit reticulocyte lysate (Promega) was used with Luciferase control RNA (Promega) as template for translation+ Per reaction, 7+5 mL of lysate was preincubated with or without 1126 N. Böddeker et al.
GS7128 in a range of concentrations+ Amino acid mix (20 mM) and luciferase RNA (0+25 mg) were added and translation was allowed to proceed for 1 h at 30 8C+ Luciferase assay reagent was added to the reaction and luciferase activity was measured in a luminometer+ IC 50 results were calculated using Sigmaplot+
Initiation reaction
Cell-free translation extracts were programmed with a heterologous mRNA (PinPoint control RNA, Promega) and formation of an initiation complex was measured using [ 35 S]methionine+ Reactions contained 2 mg mRNA, 100 pmol tRNA (fMet specific), 5 mCi [ 35 S]methionine, 5 mL S30 extract, 1 mg/mL puromycin, and 7 mL premix (Promega) in a final volume of 20 mL+ Compounds were added at 5 mg/mL GS7128, 10 mg/mL tetracycline (TET), or 100 mg/mL ATA, respectively+ Samples were incubated for 10 min at 37 8C, diluted with 500 mL of ice-cold buffer A, and filtrated over glass-microfiber filters+
Poly(U) translation
Cell-free translation extracts were programmed with poly(U) template to determine incorporation of [ 14 C]phenylalanine+ Reactions contained 4 mg poly(U) (Sigma), 50 pmol tRNA Phe , 0+05 mCi [ 14 C]phenylalanine, 5 mL S30 extract, and 7 mL premix (Promega) in a final volume of 20 mL+ Samples were incubated for 30 min at 37 8C, precipitated with 500 mL icecold TCA, boiled for 10 min, cooled on ice, and filtrated over glass-microfiber filters+
Preparation of translation extracts from S. aureus
Translation extracts were prepared essentially as described previously (Mahmood et al+, 1991 )+ Briefly, S. aureus cells were grown in brain heart infusion medium (Gibco), harvested by centrifugation, and washed once with buffer T (10 mM Tris-Cl, pH 7+4, 15 mM MgCl 2 , 50 mM KCl, 6 mM b-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride) containing 1 M NH 4 Cl+ Cells were resuspended in buffer T, lysostaphin was added to a final concentration of 1 mg/mL, and the suspension was incubated for 15 min at 37 8C+ Cells were further disrupted by pulling the viscous lysate several times through a syringe using decreasing needle sizes+ The lysate was centrifuged for 30 min at 12,000 rpm and the resulting supernatant was aliquoted and stored at Ϫ80 8C+ Preparation of ribosomes E. coli MRE600 strain was grown in standard LB medium, the cells harvested by centrifugation, and washed once with buffer A (10 mM Tris, pH 7+4, 10 mM MgCl 2 , 60 mM NH 4 Cl, 5 mM b-mercaptoethanol)+ Cells were resuspended in buffer A with the addition of lysozyme (300 mg/mL) and DNAse (1 mg/mL), incubated for 20 min on ice, and broken by sonication+ Cytoplasmic extract was obtained by centrifugation (30 min at 30,000 ϫ g) and collection of the supernatant+ Ribosomes were pelleted in a second centrifugation step (1 h at 100,000 ϫ g) and resuspended in buffer A in 1/10 of the original volume+ The supernatant was designated S100 and was kept for charging of tRNAs (see below)+ KCl was added to the resuspended ribosomal pellet at a final concentration of 0+5 M and the suspension was incubated for 30 min at 4 8C+ Salt-washed ribosomes were recovered by centrifugation through a sucrose cushion (30% sucrose in buffer A with 0+5 M KCl) for 1 h at 100,000 ϫ g, and resuspended in buffer A+ After extensive dialysis against buffer A, aliquots were frozen and stored at Ϫ80 8C+
Purification of elongation factors
Plasmids containing cloned EF-Tu and EF-G were a gift from Kate Lieberman (University of California, Santa Cruz)+ Both proteins were expressed as histidine-tagged fusions and purified using a Ni-NTA resin (Qiagen) and elution with imidazole (Moazed & Noller, 1989; Wilson & Noller, 1998 )+ They were dialyzed against and stored in 10 mM Tris, pH 8+0, 20 mM NaCl, 50% glycerol (EF-G) and 10 mM Tris, pH 7+4, 60 mM NH 4 Cl, 50% glycerol (EF-Tu) at Ϫ80 8C+ Charging of tRNA E. coli tRNA Phe was charged with [ 14 C]phenylalanine, essentially following published procedures (Moazed & Noller, 1989 )+ Briefly, 200 mg tRNA was incubated with 50 mM [ 14 C]phenylalanine (Amersham) in 50 mM HEPES, pH 7+4, 10 mM MgCl 2 , 100 mM KCl, 5 mM b-mercaptoethanol and the addition of DEAE-purified S100 extract for 30 min at 37 8C+ After addition of 1/10 vol+ sodium acetate, pH 5+0, the product was extracted with phenol, precipitated with ethanol, and resuspended in 2 mM K-acetate, pH 5+0+ Unbound phenylalanine was removed by centrifugation through a MicroSpin G-25 column (Amersham)+ For the synthesis of [ 14 C]-N-acetyl-Phe-tRNA Phe , the charged tRNA was resuspended in 0+2 M Na-acetate, pH 5+0, followed by the addition of 1/100 vol+ of acetic anhydride every 15 min during a total incubation of 1 h on ice+ The tRNA was precipitated with ethanol and column purified as before+
Elongation cycle
All reactions contained 80 pmol of salt-washed ribosomes and were carried out in RB buffer (20 mM HEPES, 6 mM MgCl 2 , 150 mM NH 4 Cl, 4 mM b-mercaptoethanol)+ For [ 14 C]-N-acetyl-Phe-tRNA Phe binding, the tRNA was added in a fivefold excess over ribosomes, and incubated with 0+5 A poly(U) for 20 min at 37 8C+ Duplicate samples were filtrated over glass-microfiber filters and measured in a scintillation counter+ For enzymatic [
14 C]-Phe-tRNA Phe binding to the A-site, the P-site was first blocked by adding deacyl tRNA Phe , after which the charged tRNA was added as a ternary complex with EF-Tu+ For this, 150 pmol EF-Tu were incubated for 5 min at 30 8C with 100 pmol of charged tRNA, 5 mM GTP in 20 mM HEPES, 7 mM MgCl 2 , 45 mM NH 4 Cl, 15 mM KCl+ Incubation together with the ribosome mix proceeded for 10 min at 37 8C+ After this, samples were divided and processed (1) by filter binding as described above, (2) by adding puromycin, and (3) by adding 20 pmol EF-G in 0+1 mM GTP+ The puromycin reactions contained 1 mM drug and were allowed to incubate on ice for 1 h+ Formed dipeptides were extracted with 1 mL ethylacetate after addition of 100 mL 0+3 M sodium acetate, pH 5+5, saturated with MgSO 4 , and Mechanism of action of GS7128 1127 counted in a scintillation counter+ Translocation reaction with EF-G was incubated for 10 min at 37 8C, after which samples were subjected to both filtration and puromycin reaction as described above+
MICs
MICs were determined by microdilution method in MH medium, as described by the National Committee for Clinical Laboratory Standards (NCCLS; 1997)+ Reference antibiotics tetracycline and ampicillin were included as performance standards, using NCCLS guidelines (National Committee for Clinical Laboratory Standards, 1998)+ For evaluating effects of media, AOAC defined synthetic medium (Difco) was substituted for MH, with or without the addition of four dipeptides, each at a final concentration of 1 mM+ Dipeptides added were arg-phe, arg-leu, met-ala, and met-phe (Sigma)+
Selection of GS7128-resistant mutants of S. aureus
Wild-type S. aureus cells were plated on Mueller-Hinton agar containing 32 mg/mL GS7128+ Colonies appearing after 3 days of incubation were transferred to fresh GS7128-containing plates for further analysis+
